GtoPdb Ligand ID: 10353

Synonyms: MCLA-117 | MCLA117 | PB9122
Compound class: Antibody
Comment: Tepoditamab (MCLA-117) is a bispecific monoclonal antibody that binds CLEC12A on myeloid cells and CD3ε on cytotoxic T cells. It is being developed by Merus as a novel therapy for acute myeloid leukemia (AML) [1].
Compound class Antibody
International Nonproprietary Names
INN number INN
10766 tepoditamab
MCLA-117 | MCLA117 | PB9122
Database Links
Specialist databases
IMGT/mAb-DB 812
Other databases
GtoPdb PubChem SID 384403634
Search PubMed clinical trials tepoditamab
Search PubMed titles tepoditamab
Search PubMed titles/abstracts tepoditamab